Results 21 to 30 of about 13,844,580 (194)

Simvastatin and cholesterol physiological based pharmacokinetics model (PBPK)

open access: yes, 2023
This repository provides the simvastatin and cholesterol physiological based pharmacokinetics model (PBPK). If you have any questions or problems please open an issue FundingFlorian Bartsch and Matthias König is supported by the Federal Ministry of ...
König, Matthias, Bartsch, Florian
core   +2 more sources

Increasing application of pediatric physiologically based pharmacokinetic models across academic and industry organizations

open access: yesCPT: Pharmacometrics & Systems Pharmacology, 2022
There has been a significant increase in the use of physiologically based pharmacokinetic (PBPK) models during the past 20 years, especially for pediatrics.
Trevor N. Johnson   +2 more
doaj   +1 more source

Physiologically Based Pharmacokinetic Modeling of Cefadroxil in Mouse, Rat, and Human to Predict Concentration–Time Profile at Infected Tissue

open access: yesFrontiers in Pharmacology, 2021
The aim of this study was to develop physiologically based pharmacokinetic (PBPK) models capable of simulating cefadroxil concentrations in plasma and tissues in mouse, rat, and human.
Zhongxia Tan   +3 more
doaj   +1 more source

Metoprolol physiological based pharmacokinetics model (PBPK)

open access: yes, 2021
This repository provides the metoprolol physiological based pharmacokinetics/pharmacodynamics model (PBPK/PD). If you have any questions or problems please open an issue FundingMatthias König is supported by the Federal Ministry of Education and Research
König, Matthias, Ogata, Paula
core   +1 more source

Guide to development of compound files for PBPK modeling in the Simcyp population‐based simulator

open access: yesCPT: Pharmacometrics & Systems Pharmacology, 2022
The Simcyp Simulator is a software platform for population physiologically‐based pharmacokinetic (PBPK) modeling and simulation. It links in vitro data to in vivo absorption, distribution, metabolism, excretion and pharmacokinetic/pharmacodynamic ...
Udoamaka Ezuruike   +6 more
doaj   +1 more source

Predicting the correct dose in children: Role of computational Pediatric Physiological‐based pharmacokinetics modeling tools

open access: yesCPT: Pharmacometrics & Systems Pharmacology, 2023
The pharmacokinetics (PKs) and safety of medications in particular groups can be predicted using the physiologically‐based pharmacokinetic (PBPK) model.
Xu Zhou   +5 more
doaj   +1 more source

Physiologically-Based Pharmacokinetic (PBPK) Modeling Providing Insights into Fentanyl Pharmacokinetics in Adults and Pediatric Patients

open access: yesPharmaceutics, 2020
Fentanyl is widely used for analgesia, sedation, and anesthesia both in adult and pediatric populations. Yet, only few pharmacokinetic studies of fentanyl in pediatrics exist as conducting clinical trials in this population is especially challenging ...
Lukas Kovar   +7 more
doaj   +1 more source

Physiologically-based pharmacokinetic modeling for optimal dosage prediction of olaparib when co-administered with CYP3A4 modulators and in patients with hepatic/renal impairment

open access: yesScientific Reports, 2023
This study aimed to develop a physiologically-based pharmacokinetic (PBPK) model to predict the maximum plasma concentration (Cmax) and trough concentration (Ctrough) at steady-state of olaparib (OLA) in Caucasian, Japanese and Chinese.
Dongmei Gao   +3 more
doaj   +1 more source

Indocyanine green physiological based pharmacokinetics model (PBPK)

open access: yes, 2021
This repository provides the indocyanine green physiological based pharmacokinetics model (PBPK) described in Prediction of survival after partial hepatectomy using a physiologically based pharmacokinetic model of indocyanine green liver function ...
König, Matthias, Köller, Adrian
core   +1 more source

Developing a Physiologically-Based Pharmacokinetic Model Knowledgebase in Support of Provisional Model Construction.

open access: yesPLoS Computational Biology, 2016
Developing physiologically-based pharmacokinetic (PBPK) models for chemicals can be resource-intensive, as neither chemical-specific parameters nor in vivo pharmacokinetic data are easily available for model construction.
Jingtao Lu   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy